Uroalerts Men's Health Weekly

July 21, 2026

Videos

Peer-to-Peer Clinical Conversations

Applying Biomarkers in Prostate and Testis Cancers - Joshua Lang

Joshua Lang

Joshua Lang discusses four ASCO 2026 oral abstracts.

Five-Year Outcomes and Retreatment Rates Following Prostate Artery Embolization - Diana Lopategui

Diana Lopategui reviews a Danish nationwide prospective cohort of 336 patients undergoing prostatic artery embolization from 2017-2022.

Beyond the Abstracts

Efficacy and Safety of Immune Checkpoint Blockade in Locally Advanced or Metastatic Penile Cancer: A Systematic Review and Meta-Analysis - Beyond the Abstract

Robotic Retroperitoneal Lymph-Node Dissection for Testicular Cancer: Initial Experience - Beyond the Abstract

Articles

Editor Selected Abstracts and Commentaries

Male Infertility

High frequency of sperm function defects in normozoospermic infertile men.

Isotretinoin for the treatment of severe male infertility.

AI-based techniques in sperm detection.

The impact of fresh versus cryopreserved testicular sperm on in-vitro fertilization outcomes in couples with elevated sperm DNA fragmentation: a retrospective cohort study.

Prostatitis

State-of-the-Art Review: Diagnosis and Management of Acute and Chronic Bacterial Prostatitis - Beyond the Abstract

Erectile Dysfunction

Development and validation of a LightGBM based machine learning model for predicting postoperative erectile dysfunction after robot assisted radical prostatectomy: a multicenter cohort study.

Erectile dysfunction severity and penile Doppler findings in pelvic fracture urethral injury: A descriptive cohort study.

SAPOC technique for length restoration in complex Peyronie's disease and erectile dysfunction at the time of penile prosthesis placement.

BPH - Benign Prostatic Enlargement

Trends in rates and outcomes of benign prostatic hyperplasia surgeries: a retrospective cohort study using the ACS-NSQIP database (2008-2021).

Endoscopic Outlet Surgery versus Medical Therapy for Benign Prostatic Hyperplasia: Impact on Incident Mood Disorders.

Study of risk factors of early reintervention after prostate laser photovaporization using Greenlight 180 W-XPS.

Knowledge, Attitude, and Practice Towards Benign Prostatic Hyperplasia Among Men Aged 50 and Above.

Imaging of Complications after Prostate Interventions.

Tracking outcome changes in benign prostatic hyperplasia trials: a version history review of ClinicalTrials.gov records.

Holmium Laser Enucleation of the Prostate After Prostatic Urethral Lift: The State of Bother - Beyond the Abstract

Clinical Outcomes of Benign Prostatic Hyperplasia Surgery in Men with Detrusor Underactivity Versus Normal Contractility: A Systematic Review and Meta-Analysis - Beyond the Abstract

Penile & Urethral Cancers

Predicting Pelvic Lymph-Node Metastasis in Carcinoma Penis: A Meta-Analysis of Retrospective Studies.

MicroRNAs in Penile Cancer: A Systematic Review of Diagnostic, Prognostic, and Mechanistic Evidence.

Testicular Cancer

Metastatic Testicular Germ Cell Tumor in a Patient With Neurofibromatosis Type 1: Treatment With Trametinib Based on NF1 Gene Mutation.

Cannabis use and testicular germ cell tumour subtypes in the french nationwide TESTIS case-control study.

Driving precision medicine in testicular germ cell tumors: from preclinical models to clinical applications.

Proton Beam Therapy for Testicular Seminoma: Clinical Outcomes and Toxicity From the Proton Collaborative Group Prospective Registry.

Prostate Cancer

Structured robotic surgery training in Germany: a five-year evaluation of the German curriculum for robot-assisted radical prostatectomy.

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2026 Update: Treatment of Relapsing and Metastatic Prostate Cancer.

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2026 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.

Genomic Classification to Predict Survival in Metastatic Prostate Cancer: Development of Somatic Tumor Risk Assessment for Overall Survival-Prostate.

Global research trends and hotspots in robotic-assisted prostate biopsy: a bibliometric analysis from 2008 to 2026.

CALB2 is a Mechanoresistance Gene in Metastatic Prostate Cancer.

ADT combinations with radiation for prostate cancer: A systematic review and meta-analysis.

Prognostic Significance of the Modified Glasgow Prognostic Score and Systemic Immune-Inflammation Index in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Cabazitaxel.

Lutetium-177-PSMA radioligand therapy in metastatic hormone-sensitive prostate cancer: A systematic review of efficacy, safety, and combination strategies.

Long-term oncologic outcomes of patients with grade group 1 prostate cancer and pT3a disease on final pathology.

PI-RADS-stratified MRI-based PSA Density for Predicting Adverse Pathology after Robotic-assisted Laparoscopic Radical Prostatectomy.

Emerging antibody-drug conjugates in metastatic castration-resistant prostate cancer.

Abiraterone or Enzalutamide for Patients With Metastatic Castration-Sensitive Prostate Cancer: A Nationwide Veterans Affairs Study.

Advanced Prostate Cancer: AUA/SUO Guideline Amendment (2026). Part II: Evaluation and Management of Metastatic Castration-Resistant Prostate Cancer.

Advanced Prostate Cancer: AUA/SUO Guideline Amendment (2026) Part I: Evaluation and Treatment of Biochemically Recurrent (Following Exhaustion of Local Therapy) and Metastatic Hormone-Sensitive Prostate Cancer.

The utility of PSA density for selection of targeted versus systematic transperineal prostate biopsy: A retrospective cohort study.

Development of a Unified Framework for Evaluating the Quality of Physician Communication in Prostate Cancer Treatment Consultations.

The psychosocial impact of receiving a polygenic risk score informing risk of prostate cancer.

External validation of the P-Score in the prospective, pre-biopsy DEPROMP cohort: integrated mpMRI and PSMA PET/CT risk stratification for prostate cancer detection.

Focal Therapy for Prostate Cancer: A Treatment Option Reserved for the Ideal Candi-date?

Performance of MRI-Based vs Clinical T Staging in Localized Prostate Cancer.

Optimal Imaging Strategies After Negative PSMA PET/CT Results in Patients With Prostate Cancer Biochemical Recurrence: AJR Expert Panel Narrative Review.

Association Between Physical Activity and Mortality in Men with or at Risk of Prostate Cancer: A Systematic Review.

PSMA PET in Lymph Node Staging of Prostate Cancer: From Diagnostic Accuracy to Clinical Decision-Making.

Androgen Deprivation Therapy and Cardiovascular Health: Challenges and Opportunities in Prostate Cancer Care.

Same Target, Different Tools: A Multicenter Comparison of Local Anesthesia Cognitive Fusion, General Anesthesia Fusion, and General Anesthesia Grid Prostate Biopsy - Beyond the Abstract

Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate Cancer - Beyond the Abstract

SBRT plus Abiraterone Acetate and ADT versus Abiraterone Acetate and ADT in Oligometastatic Castrate-Resistant Prostate Cancer (ARTO): Long-Term, Unplanned Overall Survival Analysis of an Open-Label, Randomised, Phase 2 Trial - Beyond the Abstract

Focal radiotherapy improves CAR T cell therapy targeting prostate cancer.

Cone Beam CT-guided Online Adaptive Radiotherapy for Prostate Stereotactic Body Radiation Therapy.

Joint modelling of PSA dynamics and prostate cancer risks: A population-based study in men without prior prostate cancer.

Feasibility & clinical utility of Comprehensive Geriatric Assessment (CGA) and interventions in older adults with prostate cancer on Androgen Deprivation Therapy (ADT); a retrospective service evaluation.

The Evolving PI-RADS Paradigm - Beyond the Abstract

The Predictive Role of [177Lu]Lu-PSMA-617 SPECT/CT Semiquantitative Parameters from the 1st RLT Cycle in Advanced mCRPC: A Preliminary Bicentric Lesion-Based Analysis - Beyond the Abstract

CONNECT WITH US

Questions or Comments? Email us at editors@urotoday.com

Digital Science Press, LLC
2011 Phaethon Lane,
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.

Add us to your address book View this email as a web page Forward to a colleague Manage your subscriptions Unsubscribe

Copyright ©2026 Digital Science Press, LLC